Related Experiment Video
Updated: Jun 3, 2026

12:26
Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay
Published on: May 3, 2018
Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75).
1Laboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Cellular and Molecular Life Sciences : CMLS
|March 29, 2011
Summary
Cyclin-dependent kinase 5 (Cdk5) phosphorylates Src kinase at S75, promoting its degradation and limiting its activity. This Cdk5-dependent phosphorylation is a key regulator of Src kinase in epithelial cells.
Area of Science:
- Molecular Biology
- Cell Signaling
- Biochemistry
Background:
- The non-receptor tyrosine kinase Src regulates crucial cellular processes like cytoskeletal contraction, adhesion, and migration.
- Src activity is normally controlled by Csk-dependent phosphorylation (Src Y530) and Cullin-5-dependent ubiquitinylation of active Src (pY419), targeting it for proteasomal degradation.
- Previous studies indicated Cyclin-dependent kinase 5 (Cdk5) limits Src activity by phosphorylating Src at S75.
Purpose of the Study:
- To investigate the role of Cdk5-dependent phosphorylation of Src at S75 in regulating Src activity and stability.
- To elucidate the mechanism by which Cdk5 influences Src degradation and cellular localization.
Main Methods:
- In vivo studies using epithelial cells to assess Src(S75) phosphorylation.
- Site-specific mutation (S75A) of Src to prevent Cdk5 phosphorylation.
- Cdk5 inhibition and suppression experiments.
- Analysis of Src phosphorylation (Y419), kinase activity, ubiquitinylation, and half-life.
Main Results:
- Cdk5-dependent phosphorylation of Src(S75) promotes ubiquitin-dependent degradation of Src, restricting active Src availability.
- Src(S75) phosphorylation occurs in vivo in epithelial cells and is associated with active Src.
- Inhibition or mutation of Cdk5 phosphorylation sites increased Src(Y419) phosphorylation, kinase activity, and Src stability, leading to cytoskeletal changes.
Conclusions:
- Cdk5-dependent phosphorylation of Src(S75) is a significant physiological mechanism for regulating intracellular Src activity.
- This pathway acts in concert with other regulatory mechanisms to control Src kinase function.
- Understanding this regulation provides insights into cellular processes controlled by Src.
Related Concept Videos
Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
